- Home
- CYRX
CYRX
CryoPort Inc.
as 03-28-2025 4:00pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 310.4M | IPO Year: | N/A |
| Target Price: | $11.33 | AVG Volume (30 days): | 669.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.58 - $20.11 | Next Earning Date: | 03-04-2025 |
| Revenue: | $228,385,000 | Revenue Growth: | -2.09% |
| Revenue Growth (this year): | 9.31% | Revenue Growth (next year): | 8.36% |
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 24 '25 | Sell | $6.94 | 1,070 | $7,427.51 | 190,349 | |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 24 '25 | Sell | $6.94 | 1,349 | $9,364.22 | 84,087 | |
| SHELTON JERRELL | CYRX | President, CEO | Mar 24 '25 | Sell | $6.94 | 2,980 | $20,685.97 | 762,419 | |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 14 '25 | Sell | $6.29 | 1,659 | $10,437.93 | 190,349 | |
| SHELTON JERRELL | CYRX | President, CEO | Mar 14 '25 | Sell | $6.29 | 4,620 | $29,067.65 | 762,419 | |
| ZECCHINI EDWARD J | CYRX | Chief Digital and Tech Officer | Mar 14 '25 | Sell | $6.29 | 1,140 | $7,172.54 | 66,911 | |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 9 '25 | Sell | $4.88 | 1,583 | $7,723.62 | 84,087 | |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '25 | Sell | $4.88 | 4,173 | $20,360.48 | 762,419 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
MT Newswires
5 days ago
CryoPort Shares Rise After Upgrade From UBS
MT Newswires
5 days ago
UBS Upgrades CryoPort to Buy From Neutral, Maintains $10 Price Target
Insider Monkey
11 days ago
Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?
Zacks
16 days ago
CryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains?
PR Newswire
17 days ago
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories
Simply Wall St.
23 days ago
Cryoport Full Year 2024 Earnings: EPS Misses Expectations
GuruFocus.com
24 days ago
CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
Zacks
25 days ago
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
Compare CYRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.